Clinical impact of HLA class I expression in rectal cancer.
Speetjens FM, de Bruin EC, Morreau H, Zeestraten EC, Putter H, van Krieken JH, van Buren MM, van Velzen M, Dekker-Ensink NG, van de Velde CJ, Kuppen PJ.
Speetjens FM, et al.
Cancer Immunol Immunother. 2008 May;57(5):601-9. doi: 10.1007/s00262-007-0396-y. Epub 2007 Sep 15.
Cancer Immunol Immunother. 2008.
PMID: 17874100
Free PMC article.